Uncategorized

Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipeline

Published

1 day ago

on

On Friday, Kailera Therapeutics raised a record-setting $625 million through an IPO on the Nasdaq. Founded with backing from Bain Capital Life Sciences, and a pipeline of obesity assets from China’s Hengrui …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version